Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) per Share, Anti-dilutive Securities Excluded from Computation of Net Income (Loss) per Share (Details)

v3.23.3
Net Income (Loss) per Share, Anti-dilutive Securities Excluded from Computation of Net Income (Loss) per Share (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Series A, Series B and RDO Warrants [Member]        
Net Income (Loss) Per Share [Abstract]        
Antidilutive securities excluded from computation of net income (loss) per share (in shares) 7,204,299 7,281,977 7,204,299 7,281,977
Stock Options [Member]        
Net Income (Loss) Per Share [Abstract]        
Antidilutive securities excluded from computation of net income (loss) per share (in shares) 2,554,806 2,938,044 3,469,389 2,938,044
RSUs [Member]        
Net Income (Loss) Per Share [Abstract]        
Antidilutive securities excluded from computation of net income (loss) per share (in shares) 237,244 0 282,008 0
Former Rexahn Warrants [Member]        
Net Income (Loss) Per Share [Abstract]        
Antidilutive securities excluded from computation of net income (loss) per share (in shares) 58,597 63,734 58,597 63,734